Cancer diagnostics maker Accustem files for Nasdaq uplisting, $11M offering

Initial public offering hologram, night panoramic city view of Bangkok. The financial center for multinational corporations in Asia. The concept of boosting the growth by IPO process. Double exposure.

2nd illustrations and pictures/iStock by way of Getty Images

Oncology diagnostics developer Accustem Sciences (OTCQB:ACUT) has filed to uplist its shares to Nasdaq and lift $11M.

Accustem mentioned in a submitting that it was seeking to supply 1.5M shares on the

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!